These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33904416)

  • 1. Prevalence of dyslipidaemia and factors associated with dyslipidaemia among South Asian adults: The Center for Cardiometabolic Risk Reduction in South Asia Cohort Study.
    Fatmi Z; Kondal D; Shivashankar R; Iqbal R; Khan AA; Mohan D; Pradeepa R; Gupta R; Ali MK; Ajay VS; Mohan V; Kadir MM; Narayan KMV; Prabhakaran D; Tandon N
    Natl Med J India; 2020; 33(3):137-145. PubMed ID: 33904416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the "South Asian Phenotype" Unique to South Asians?: Comparing Cardiometabolic Risk Factors in the CARRS and NHANES Studies.
    Patel SA; Shivashankar R; Ali MK; Anjana RM; Deepa M; Kapoor D; Kondal D; Rautela G; Mohan V; Narayan KM; Kadir MM; Fatmi Z; Prabhakaran D; Tandon N;
    Glob Heart; 2016 Mar; 11(1):89-96.e3. PubMed ID: 27102026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High burden of prediabetes and diabetes in three large cities in South Asia: The Center for cArdio-metabolic Risk Reduction in South Asia (CARRS) Study.
    Deepa M; Grace M; Binukumar B; Pradeepa R; Roopa S; Khan HM; Fatmi Z; Kadir MM; Naeem I; Ajay VS; Anjana RM; Ali MK; Prabhakaran D; Tandon N; Mohan V; Narayan KM;
    Diabetes Res Clin Pract; 2015 Nov; 110(2):172-82. PubMed ID: 26432412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study.
    Mohamed-Yassin MS; Baharudin N; Daher AM; Abu Bakar N; Ramli AS; Abdul-Razak S; Mohamed Noor Khan NA; Mohamad M; Yusoff K
    BMC Cardiovasc Disord; 2021 Mar; 21(1):149. PubMed ID: 33757445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey.
    Zdrojewski T; Solnica B; Cybulska B; Bandosz P; Rutkowski M; Stokwiszewski J; Gaciong Z; Banach M; Wojtyniak B; Pencina M; Wyrzykowski B
    Kardiol Pol; 2016; 74(3):213-23. PubMed ID: 27004543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Sleep Duration and Disturbances With Hypertension in Metropolitan Cities of Delhi, Chennai, and Karachi in South Asia: Cross-Sectional Analysis of the CARRS Study.
    Shivashankar R; Kondal D; Ali MK; Gupta R; Pradeepa R; Mohan V; Kadir MM; Narayan KMV; Tandon N; Prabhakaran D; Peasey A
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic status and cardiovascular risk in urban South Asia: The CARRS Study.
    Ali MK; Bhaskarapillai B; Shivashankar R; Mohan D; Fatmi ZA; Pradeepa R; Masood Kadir M; Mohan V; Tandon N; Narayan KM; Prabhakaran D;
    Eur J Prev Cardiol; 2016 Mar; 23(4):408-19. PubMed ID: 25917221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa.
    Pitso L; Mofokeng TRP; Nel R
    BMC Endocr Disord; 2021 Aug; 21(1):159. PubMed ID: 34365977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Dyslipidaemia Using an Algorithm of Lipid Profile Measures among Newly Diagnosed Type II Diabetes Mellitus Patients: A Cross-Sectional Study at Dormaa Presbyterian Hospital, Ghana.
    Anto EO; Obirikorang C; Annani-Akollor ME; Adua E; Donkor S; Acheampong E; Asamoah EA
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31330902
    [No Abstract]   [Full Text] [Related]  

  • 10. Temporal changes in diabetes prevalence and achievement of care goals in urban South Asia from 2010 to 2016 - The Center for Cardio-metabolic Risk Reduction in South Asia Study.
    Anjana RM; Deepa M; Subashini R; Patel SA; Kondal D; Unnikrishnan R; Tandon N; Prabhakaran D; Narayan KMV; Kadir MM; Mohan V; Ali MK
    Diabet Med; 2021 Feb; 38(2):e14424. PubMed ID: 33067811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
    Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
    Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
    Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
    PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Younger age of escalation of cardiovascular risk factors in Asian Indian subjects.
    Gupta R; Misra A; Vikram NK; Kondal D; Gupta SS; Agrawal A; Pandey RM
    BMC Cardiovasc Disord; 2009 Jul; 9():28. PubMed ID: 19575817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities.
    Masilela C; Adeniyi OV; Benjeddou M
    Sci Rep; 2022 Jan; 12(1):337. PubMed ID: 35013433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National high prevalence, and low awareness, treatment and control of dyslipidaemia among people aged 15-69 years in Mongolia in 2019.
    Pengpid S; Peltzer K
    Sci Rep; 2022 Jun; 12(1):10478. PubMed ID: 35729323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study of the prevalence and correlates of tobacco use in Chennai, Delhi, and Karachi: data from the CARRS study.
    Berg CJ; Ajay VS; Ali MK; Kondal D; Khan HM; Shivashankar R; Pradeepa R; Mohan D; Fatmi Z; Kadir MM; Tandon N; Mohan V; Narayan KM; Prabhakaran D
    BMC Public Health; 2015 May; 15():483. PubMed ID: 25958327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, patterns and predictors of dyslipidaemia in Nigeria: a report from the REMAH study.
    Chori B; Danladi B; Nwakile P; Okoye I; Abdullahi U; Zawaya K; Essien I; Sada K; Nwegbu M; Ogedengbe J; Aje A; Isiguzo G; Odili A
    Cardiovasc J Afr; 2022 Mar-Apr 23; 33(2):52-59. PubMed ID: 34779815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based survey.
    Asiki G; Murphy GA; Baisley K; Nsubuga RN; Karabarinde A; Newton R; Seeley J; Young EH; Kamali A; Sandhu MS
    PLoS One; 2015; 10(5):e0126166. PubMed ID: 25974077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.
    Odenigbo CU; Oguejiofor OC; Odenigbo UM; Ibeh CC; Ajaero CN; Odike MA
    Niger J Clin Pract; 2008 Dec; 11(4):330-5. PubMed ID: 19320405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.